PDT Partners LLC purchased a new position in shares of IBEX Limited (NASDAQ:IBEX - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 14,890 shares of the company's stock, valued at approximately $363,000. PDT Partners LLC owned 0.11% of IBEX at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in IBEX. Wells Fargo & Company MN increased its position in shares of IBEX by 24.5% in the 4th quarter. Wells Fargo & Company MN now owns 5,024 shares of the company's stock worth $108,000 after purchasing an additional 990 shares during the last quarter. Martingale Asset Management L P increased its position in shares of IBEX by 2.3% in the 1st quarter. Martingale Asset Management L P now owns 44,723 shares of the company's stock worth $1,089,000 after purchasing an additional 999 shares during the last quarter. Tower Research Capital LLC TRC increased its position in shares of IBEX by 267.4% in the 4th quarter. Tower Research Capital LLC TRC now owns 1,925 shares of the company's stock worth $41,000 after purchasing an additional 1,401 shares during the last quarter. Barclays PLC increased its position in shares of IBEX by 6.8% in the 4th quarter. Barclays PLC now owns 22,046 shares of the company's stock worth $473,000 after purchasing an additional 1,410 shares during the last quarter. Finally, US Bancorp DE bought a new stake in shares of IBEX in the 1st quarter worth about $41,000. Hedge funds and other institutional investors own 81.24% of the company's stock.
IBEX Stock Down 2.5%
Shares of IBEX traded down $0.74 during midday trading on Wednesday, hitting $28.59. The company had a trading volume of 18,693 shares, compared to its average volume of 157,500. The company's 50 day moving average price is $29.48 and its 200 day moving average price is $27.35. The stock has a market cap of $382.27 million, a price-to-earnings ratio of 12.49 and a beta of 0.77. IBEX Limited has a 52 week low of $16.38 and a 52 week high of $32.08. The company has a quick ratio of 1.67, a current ratio of 1.67 and a debt-to-equity ratio of 0.01.
Insider Transactions at IBEX
In other news, insider Paul Joseph Inson sold 10,000 shares of the business's stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $30.00, for a total value of $300,000.00. Following the completion of the sale, the insider owned 7,352 shares of the company's stock, valued at approximately $220,560. The trade was a 57.63% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Mohammedulla Khaishgi sold 5,000 shares of the business's stock in a transaction dated Monday, June 16th. The shares were sold at an average price of $28.01, for a total transaction of $140,050.00. Following the sale, the director directly owned 2,312 shares of the company's stock, valued at approximately $64,759.12. This represents a 68.38% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 70,220 shares of company stock valued at $2,069,150. Insiders own 6.72% of the company's stock.
About IBEX
(
Free Report)
IBEX Limited provides end-to-end technology-enabled customer lifecycle experience solutions in the United States and internationally. The company products and services portfolio includes ibex Connect, that offers customer service, technical support, revenue generation, and other revenue generation outsourced back-office services through the CX model, which integrates voice, email, chat, SMS, social media, and other communication applications; ibex Digital, a customer acquisition solution that comprises digital marketing, e-commerce technology, and platform solutions; and ibex CX, a customer experience solution, which provides a suite of proprietary software tools to measure, monitor, and manage its clients' customer experience.
Featured Articles

Before you consider IBEX, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and IBEX wasn't on the list.
While IBEX currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.